Table 2 Comparison of ERα, PR (percentage of positively stained nuclei) and HER2 (DAKO scores) expression in paired samples of 23 breast cancers routinely processed (control) or undergoing decalcification in EDTA, Christensen’s buffer (CBM with or CB without microwave) or Formical-4 (F4)
Sample | ERα | PR | HER2 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Control | CBM | CB | EDTA | F4 | Control | CBM | CB | EDTA | F4 | Control | CBM | CB | EDTA | F4 | |
1 | 100 | 100 | 100 | 100 | 30 | 1 | 5 | 5 | 1+ | 0 | 1+ | 0 | |||
2 | 90 | 100 | 100 | 100 | 1 | 0 | 0 | 0 | 0 | 0 | 1+ | 1+ | |||
3 | 90 | 100 | 100 | 100 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
4 | 100 | 90 | 100 | 100 | 100 | 100 | 75 | 90 | 2+ | 0 | 0 | 1+ | |||
5 | 100 | 90 | 75 | 100 | 90 | 75 | 90 | 100 | 3+ | 1+ | 2+ | 3+ | |||
6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3+ | 3+ | 3+ | 3+ | |||
7 | 90 | 50 | 75 | 90 | 100 | 90 | 100 | 10 | 0 | 0 | 0 | 0 | |||
8 | 97 | 90 | 90 | 100 | 97 | 100 | 100 | 90 | 0 | 0 | 0 | 0 | |||
9 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
10 | 100 | 100 | 90 | 100 | 65 | 75 | 65 | 35 | 0 | 0 | 1+ | 1+ | |||
11 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
12 | 100 | 75 | 90 | 60 | 20 | 75 | 0 | 0 | 0 | ||||||
13 | 100 | 95 | 75 | 75 | 90 | 95 | 65 | 65 | 0 | 0 | 0 | 0 | |||
14 | 100 | 100 | 100 | 75 | 100 | 100 | 100 | 75 | 0 | 0 | 0 | 0 | |||
15 | 100 | 75 | 75 | 75 | 100 | 100 | 100 | 90 | 0 | 0 | 0 | 0 | |||
16 | 35 | 75 | 35 | 50 | 0 | 75 | 65 | 75 | 3+ | 3+ | 3+ | 3+ | |||
17 | 100 | 75 | 90 | 90 | 5 | 75 | 90 | 65 | 0 | 0 | 0 | 0 | |||
18 | 1 | 0 | 10 | 0 | 10 | 10 | 2 | 10 | 0 | 0 | 0 | 0 | |||
19 | 90 | 75 | 100 | 20 | 100 | 90 | 100 | 75 | 0 | 0 | 0 | 0 | |||
20 | 100 | 90 | 90 | 90 | 50 | 35 | 50 | 50 | 1+ | 1+ | 1+ | 1+ | |||
21 | 100 | 100 | 100 | 65 | 90 | 90 | 0 | 0 | 0 | ||||||
22 | 100 | 100 | 95 | 95 | 65 | 65 | 90 | 90 | 0 | 0 | 0 | 0 | |||
23 | 100 | 95 | 75 | 100 | 95 | 75 | 0 | 0 | 0 |